
Paul Hudson
Paul Hudson is the Chief Executive Officer of Sanofi, a global biopharmaceutical company. Under his leadership, Sanofi has made significant investments in China, particularly in biopharmaceutical manufacturing and innovation, including a recent €1 billion investment to expand its production capacity in the Beijing Economic-Technological Development Area. Hudson's commitment to enhancing healthcare solutions aligns with the growing demand for diabetes treatments and advanced medical technologies.
Born on Jan 01, 1967 (58 years old)
Global Media Ratings
Countries Mentioned
Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
---|---|---|---|---|---|---|---|---|
China | 6 | 8.17 | 0.30% | +10% | 1,402,112,000 | 4,560,837 | $14,000,000 | 45,540$ |
Taiwan | 1 | 7.00 | 0.10% | +0% | 23,816,775 | 23,675 | $670,000 | 666$ |
North Macedonia | 1 | 8.00 | 0.09% | +0% | 2,083,374 | 1,863 | $12,800 | 11$ |
Totals | 8 | 1,428,012,149 | 4,586,375 | $14,682,800 | 46,217$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
North Macedonia:
Paul Hudson, the CEO of Sanofi, participated in the meeting and praised China's stable economic growth.
8
China:
Paul Hudson, the CEO of Sanofi, announced a significant investment in a new insulin production facility in Beijing, marking a major milestone for the company in China.
9
China:
Paul Hudson mentioned that Sanofi has continuously deepened its presence in China since 1982.
8
China:
Paul Hudson, CEO of Sanofi, highlighted the opportunities in China's market.
8
China:
Paul Hudson, CEO of Sanofi, spoke at the meeting with Xi Jinping.
8
Taiwan:
Paul Hudson of Sanofi SA was present at the meeting with Xi Jinping.
7
China:
Paul Hudson, CEO of Sanofi, was one of the speakers at the meeting.
8
China:
Paul Hudson, CEO of Sanofi, was one of the speakers at the meeting.
8
Switzerland:
Paul Hudson was another candidate for the CEO position at Novartis.
5
China:
Paul Hudson emphasized the importance of high standards and sustainability in the new Sanofi production base.
8